SUBSCRIBE
SUBSCRIBE
News   Business

Vetoquinol Earnings for 2007 Attest to Strength of Business Growth Model

March 18, 2008 | 
1 min read

LURE, France--(BUSINESS WIRE)--Regulatory News: The Vétoquinol (Paris:VETO) board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements

Earnings Europe
MORE ON THIS TOPIC
Entrance to Vertex's office in Boston, Massachusetts
Earnings
Vertex Tops Q3 Forecast on Strength of Cystic Fibrosis Sales, Raises Full-Year Revenue Guidance
November 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Reaching an agreement. Businessmen shake hands and make a deal. vector
GLP-1
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
November 4, 2024
 · 
1 min read
 · 
Annalee Armstrong
Sign outside BioNTech's building in Germany
Earnings
BioNTech Handily Beats Q3 Expectations, Trims Full-Year Revenue Guidance
November 4, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: Regeneron logo on a light brown building
Earnings
Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure
November 1, 2024
 · 
2 min read
 · 
Tristan Manalac